ncRNA name
hsa-miR-31
Specific or universal ncRNAs
Universal ncRNAs
Class
MicroRNA
Biomarker
Yes
Biomarker application
Treatment
Upstream regulatory factors
Not available
Downstream target
NDRG3
Cancer name
Hepatocellular Carcinoma
Cancer site
Liver
Treatment type
Chemotherapy
Drug
Adriamycin
Impact of wild-type ncRNA on chemotherapy resistance
Down
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Down
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
MiR-31 and NDRG3 sensitized HCC cancer cells to adriamycin.
Tissue resource
hepatocellular carcinoma tissues and nontumorous liver tissues
human hepatocellular carcinoma cell lines HepG2
human hepatocellular carcinoma cell lines Hep3B
human hepatocellular carcinoma cell lines 7402
human hepatocellular carcinoma cell lines Huh7
normal liver cell lines LO2
Experiment
qRT-PCR,Western blot
Institute
Weifang Hospital of Traditional Chinese Medicine
American Type Culture Collection
Country
China
USA
Continent
Asia
Amercia